Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-D-aspartate 1 gene (GRIN1) in schizophrenic patients

Psychiatric Genetics

Volumn 12, Issue 4, 2002, Pages 225-230

  Hung, Chao Chun ^a   Chen, Hsiang Yin ^a   Chen, Chia Hsiang ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Genetics; Glutamate; Mutation; Polymorphism; Schizophrenia

Indexed keywords

GENE PRODUCT; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BEHAVIOR; CHINESE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GRIN1 GENE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROTRANSMISSION; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TAIWAN; TRANSGENIC MOUSE;

ANTIPSYCHOTIC AGENTS; BASE SEQUENCE; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, N-METHYL-D-ASPARTATE; REFERENCE VALUES; SCHIZOPHRENIA;

MUS MUSCULUS;

EID: 0036915223     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200212000-00005     Document Type: Article

References (25)

1. Abi-Saab WM, D'Sauza DC, Moghaddam B, Krystal JH (1998). The NMDA antagonist model for schizophrenia: Promise and pitfalls. Pharmacopsychiatry 31(Suppl 2):104-109.
2. Antonarakis SE, the Nomenclature Working Group (1998). Recommendations for a nomenclature system for human gene mutations. Hum Mutat 11:1-3.
3. Breese CR, Freedman R, Leonard SS (1995). Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res 674:82-90.
4. Chen ACH, McDonald B, Moss SJ, Gurling HMD (1998). Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis- and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment. Mol Brain Res 54:92-100.
5. Forrest D, Yuzaki M, Soares HD, Ng L, Luk DC, Sheng M, et al. (1994). Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13:325-338.
6. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA (2000). Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor sub-units in subregions of human hippocampus: Effects of schizophrenia. Am J Psychiatry 157:1141-1149.
7. Goff DC, Wine L (1997). Glutamate in schizophrenia: Clinical and research implications. Schizophr Res 27:157-168.
8. Harrison PJ, McLaughlin D, Kerwin RW (1991). Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337:450-452.
9. Hollmann M, Heinemann S (1994). Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
10. Ibrahim HM, Hogg AJ, Jr, Healy DJ, Haroutunian V, Davis K, Meador-Woodruff JH (2000). Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 157:1811-1823.
11. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
12. Kukita Y, Tahira T, Sommer SS, Hayashi K (1997). SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 10:400-407.
13. Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S (1994). Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76:427-437.
14. Liu Q, Feng J, Sommer S (1996). Bi-directional dideoxy fingerprinting (Bi-ddF): A rapid method for quantitative detection of mutations in genomic regions of 300-600 bp. Hum Mol Genet 5:107-114.
15. Meador-Woodruff JH, King RE, Damask SP, Bovenkerk KA (1996). Differential regulation of hippocampal AMPA and kainite receptor subunit expression by haloperidol and clozapine. Mol Psychiatry 1:41-53.
16. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:364-427.
17. Moriyashi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S (1991). Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37.
18. Nakanishi S (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258:597-603.
19. Nakanishi S, Masu M (1994). Molecular diversity and functions of glutamate receptors. Annu Rev Biophys Biomol Struct 23:319-348.
20. Olney JW, Farber NB (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
21. Rice SR, Niu N, Berman DB, Heston LL, Sobell JL (2001). Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry 6:274-284.
22. Sakurai K, Toru M, Yamakawa-Kobayashi K, Arinami T (2000). Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neurosci Lett 296:168-170.
23. Sarkar G, Yoon H-S, Sommer S (1992). Dideoxy finger-printing (ddF): A rapid and efficient screen for the presence of mutations. Genomics 13:441-443.
24. Toyoda H, Takahata R, Inayama Y, Sakai J, Matsumura H, Yoneda H, et al. (1997). Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats. Neurochem Res 22:249-252.
25. Zimmer M, Fink TM, Franke Y, Lichter P, Spiess J (1995). Cloning and structure of the gene encoding the human N-methyl-D-aspartate receptor (NMDAR1). Gene 159:219-223.